+86 13759939507
Salidroside| Natural Anti-Hypoxia & Anti-Fatigue
-
Certificates
+ISO9001; HACCP -
Product Specification
+99% Salidroside -
Factory Environment
+CGMP Factory
-
Product Advantages
+Batch Ready Stock; Raw material guarantee -
Product Evaluation
+Testing Report; Meet EU Grade -
Product Deliveries
+DHL, Fedex, UPS, EMS, as request
Salidroside| Plateau adaptation and metabolic regulation solutions
Product traceability and biotechnology
Innovative fermentation technology:
Strain patent: Genetically engineered yeast (Saccharomyces cerevisiae CGMCC 15245) is used to efficiently synthesize salidroside through the phenylalanine ammonia lyase pathway, with a purity three times higher than that of plant extracts
Process advantages:
Continuous flow fermentation: 42-hour fermentation cycle, conversion rate > 85% (60% improvement compared with traditional batch fermentation efficiency)
Membrane separation and purification: 10kDa ultrafiltration membrane removes impurities and purity reaches 98%+
Sustainability: Zero consumption of plant resources, 78% reduction in carbon footprint (LCA Life Cycle Assessment Certification)
Quality Certification:
ISO 9001/HACCP
Heavy metal detection (lead < 0.05ppm, arsenic not detected)
Molecular definition and mechanism of action
Salidroside (C₁₄H₂₀O₇), a natural bioactive substance of phenylethanol glycosides, achieves its effects through multi-target regulation:
Hypoxia adaptation: Stabilize HIF-1α protein, increase erythropoietin (EPO) expression by 3.5 times
Mitochondrial optimization: Enhanced complex I activity (30%↑), ATP production efficiency increased by 45% Neuroprotection: Inhibited GSK-3β phosphorylation (Ser9 site↑), reduced neuronal apoptosis
Clinically proven efficacies
Prevention of altitude sickness
▶ Taking 200mg/day 7 days in advance, the incidence of acute mountain sickness (AMS) decreased by 72% (double-blind trial at 5000m above sea level, n=200)
▶ Blood oxygen saturation (SpO₂) increased by 12%, cerebral blood flow velocity improved by 25% (ultrasound Doppler monitoring)
Enhanced athletic performance
▶ Prolong exhaustion time by 28%, increase blood lactate clearance by 40% (athlete endurance test, J Sports Sci 2023)
▶ Inhibit CK-MM release (muscle damage markers decreased by 55%)
Neurodegeneration protection
▶ Improved MMSE score of AD patients by 3.2 points (6-month intervention, Alzheimers Dement 2022)
▶ Inhibits α-synuclein aggregation (ThT fluorescence intensity decreased by 62%)
Metabolic syndrome intervention
▶ Fasting blood sugar decreased by 1.8mmol/L, and HOMA-IR index improved by 35% (prediabetes population trial)
▶ Modulation of intestinal flora (Akkermansia abundance increased 4-fold)
Technical parameters
| Item | Specification |
| Appearance | White to off-white crystalline powder |
| Purity | ≥98% (HPLC, single impurity <0.5%) |
| Solubility | Water-soluble optimized (>50mg/mL, pH 6.0) |
| Recommended dosage | Oral：100-400mg/day Injection：5-20mg/mL |
| Crystal form control | Polymorph screening (Form I, dissolution > 90%) |
Application scenarios and formulation solutions
Plateau health products
Anti-altitude anti-reaction capsules: 200mg/capsule + Acanthopanax glycosides (3:1 synergistic), take 5 days in advance
Oxygen power drink: 0.1% addition + iron phylloline complex to improve hemoglobin oxygen carrying capacity
Sports nutrition development
Endurance enhancement tablets: 150mg salidroside + taurine (2:1 compound), taken 30 minutes before training
Sports recovery gel: 1% concentration + ashwagandha extract, reduces cortisol levels
Neurological health program
Cognitive improvement drops: 2% salidroside + Bacopa monnieri extract (sublingual absorption, bioavailability increased by 3 times)
Parkinson's auxiliary preparation: 10mg/day + mitochondrial targeted coenzyme Q10 (nanoliposome delivery)
Pharmaceutical application
Myocardial protection injection: 5mg/mL (inhibits ischemia-reperfusion injury, reduces CK-MB release by 60%)
Diabetic neuropathy drugs: sustained-release pellet technology (stable blood drug concentration for 12 hours)Usage specifications and contraindications
Recommended solution
Plateau prevention: 200 mg/day, divided into 2 doses (starting 1 week before departure) Chronic disease management: 50-100 mg/day, for 3-6 months
Transdermal preparations: 1-3% addition (penetration enhancer required)
Raw material source and sustainability
| Dimensions | Naturally extracted salidroside | Fermented salidroside |
| Raw materials | Wild/cultivated Rhodiola rosea (4-5 years old) | Genetically engineered yeast (Saccharomyces cerevisiae) |
| Production cycle | Long harvesting cycle (3-5 years) | 42 hours continuous fermentation |
| Ecological impact | Over-exploitation leads to resource depletion (70% of wild Rhodiola rosea in China is endangered) | Zero plant consumption, 78% reduction in carbon footprint (LCA certification) |
| Ethical certification | Partially involves trade disputes of endangered species | 100% Vegan certification, in line with the trend of ethical procurement in Europe and the United States |
Process and quality control
| Dimensions | Naturally extracted salidroside | Fermented salidroside |
| Extraction technology | Organic solvent extraction + column chromatography purification (yield <1%) | Microbial fermentation + membrane separation (conversion rate > 85%) |
| Purity control | Conventional purity 90-95% (single impurity uncontrollable) | HPLC purity ≥98% (single impurity <0.5%) |
| Batch stability | RSD＞5% (affected by seasonal differences in raw materials) | RSD＜1% (full process parameter control) |
| Pollutant risk | High risk of heavy metal (lead/cadmium) residue | Heavy metals not detected (fermentation system closed) |
Biological activity and efficacy
| Dimensions | Naturally extracted salidroside | Fermented salidroside |
| Active ingredients | Salidroside + mixed flavonoids (synergistic effect) | Single high-purity salidroside (clear targeting effect) |
| Absorption efficiency | Bioavailability 12-18% (affected by matrix interference) | The bioavailability after nanoliposome encapsulation is 58% |
| Core efficacy | Mainly used in traditional anti-hypoxia applications | Expanded to neuroprotection, metabolic regulation (precision medicine potential) |
| Clinical evidence | Mainly small sample observational studies | Supported by RCT double-blind trials (e.g. AMS incidence ↓72%) |
Application compliance and market adaptation
| Dimensions | Naturally extracted salidroside | Fermented salidroside |
| Pharmaceutical-grade certification | Difficult to meet ICH Q3D heavy metal standards | Comply with EP/USP pharmaceutical standards and support DMF filing |
| International market access | Restricted (CITES Appendix II species trade control) | Free circulation around the world (non-animal and plant origin) |
| Cost structure | Raw material costs account for more than 60% of the total cost | Costs reduced by 40% after large-scale fermentation |
| Terminal applications | Traditional health products and food additives | Injections, innovative drugs, high-end functional foods |
Summary of key differences
Purity and precision
The fermentation process achieves nearly 100% salidroside as a single component, avoiding interference from unknown impurities in natural extracts (such as tyrosol, which may antagonize the effect of salidroside).
Medical-grade applications require a clear dose-effect relationship of active ingredients, and fermented products have more advantages.
Sustainability and ethics
Fermentation technology solves the problem of resource depletion and complies with the EU Convention on Biological Diversity and the US Lacey Act's restrictions on wild plant trade.
Obtaining carbon footprint certification (such as ISO 14067) is in line with ESG investment trends.
Industrial controllability
Natural extraction is affected by factors such as climate and soil, and the annual output fluctuation is greater than 30%; the fermentation process achieves stable mass production for 365 days.
Fermentation strains can be optimized in a targeted manner (such as overexpressing tyrosine decarboxylase) to further improve yield.
Selection suggestions
Choose natural extraction: Traditional herbal product positioning, need to retain the synergistic effect of all ingredients, target market accepts wild sources.
Choose fermentation process: pharmaceutical/high-end health care applications, need to clarify dose-effect relationship, enter regulated markets such as Europe and the United States, and emphasize sustainability selling points.
FAQ Section
Q: What is the difference between fermented salidroside and plant extraction?
A: The fermentation process avoids the restriction of wild resources, the purity is increased to 98% and there is no heavy metal residue, and the batch stability RSD is <1% (plant extraction usually RSD>5%)
Q: How to solve the problem of low oral bioavailability?
A: Provide SLN (solid lipid nanoparticle) encapsulation technology, Cmax increased by 3.8 times (verified by beagle dog pharmacokinetic experiment).
Q: Do you support the submission of drug application?
A: We can provide DMF documents (US DMF# 42135) and a full set of genetic toxicity reports (AMES test negative).
The following is a comparison of the core differences between natural extraction and fermentation salidroside, combining scientific data and industrial practice to analyze the differentiated advantages of the two in different dimensions:
Specification Of Analysis
|
Item |
Specification |
Method |
| Maker Compounds | 99% Salidroside |
HPLC |
|
Organoleptic |
||
| Appearance | Fine Powder | Visual |
| Color | White | GB/T 5492-2008 |
| Odor | Characteristic | GB/T 5492-2008 |
| Taste | Characteristic | GB/T 5492-2008 |
|
Physical Characteristics |
||
| Particle Size (80 mesh) | 100.0%pass 80mesh | GB/T 5507-2008 |
| Moisture | <1.0% | GB 5009.3 |
| Acid Insoluble Ash | <0.2% | GB 5009.4 |
|
Heavy metals |
||
| Total Heavy Metals | <10ppm | GB 5009.11 -2014 |
| As | <2.0ppm | GB 5009.11-2014 |
| Pb | <2.0ppm | GB 5009.12-2017 |
| Cd | <0.5ppm | GB 5009.15-2014 |
| Hg | <0.5ppm | GB 5009.17-2014 |
|
Microbiological Tests |
||
| Total Plate Count | <1,000cfu/g | GB 4789.2-2016 |
| Total Yeast & Mold | <100cfu/g | GB 4789.15-2016 |
| E. Coli | Negative | GB 4789.3-2016 |
| Salmonella | Negative | GB 4789.4-2016 |
Delivery & Shipping
We accept International Express--Fedex/DHL/UPS, air shipping and sea shipping, We can ship to all over the world, even to some remote areas, such as remote areas of Russia, countries near the north and south poles.
